Related Experiment Video
Updated: Sep 30, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Association of peptic ulcer with Helicobacter pylori and the recurrence rate. A three year follow-up study
S A Nanivadekar1, P D Sawant, H D Patel
1Department of Gastroenterology, L.T.M. Medical College, Sion, Bombay.
Abstract:
Helicobacter pylori is associated with 70-100% of peptic ulcers. Relapse of infection has been shown to cause recurrences of ulcers in a large number of studies. We diagnosed 137 cases of peptic ulcer (121 DU; 16 GU) during a 3 year period. Of these, 117 were positive for H pylori. Sixty six of the 117 cases staying in the vicinity of the Hospital were followed up for a minimum period of 3 months upto a maximum period of 3 years. In 91 examinations there was relapse of H pylori infection and ulcer recurrence was seen in 58 (63%), whereas ulcer recurred only in 6 out of 61 examinations where H pylori had not relapsed (10%). The difference was highly significant by Chi square test. (P less than 0.001).
Insights
Helicobacter pylori infection relapse significantly increases peptic ulcer recurrence. Studies show H. pylori eradication is crucial for preventing ulcer relapses and improving patient outcomes.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Internal Medicine
Background:
- Helicobacter pylori (H. pylori) is a primary cause of peptic ulcer disease, implicated in 70-100% of cases.
- Recurrent H. pylori infections are frequently linked to ulcer relapses, necessitating effective management strategies.
Purpose of the Study:
- To investigate the direct correlation between H. pylori infection relapse and the recurrence of peptic ulcers.
- To quantify the increased risk of ulcer recurrence associated with H. pylori reinfection.
Main Methods:
- A 3-year study diagnosed 137 peptic ulcer cases (121 duodenal, 16 gastric).
- Of 117 H. pylori-positive patients, 66 were followed for 3 months to 3 years.
- H. pylori relapse and ulcer recurrence were monitored through serial examinations.
Main Results:
- H. pylori relapse occurred in 91 examinations, leading to ulcer recurrence in 58 cases (63%).
- In contrast, only 6 out of 61 examinations without H. pylori relapse showed ulcer recurrence (10%).
- The difference in ulcer recurrence rates between relapsed and non-relapsed H. pylori infections was statistically significant (P < 0.001).
Conclusions:
- H. pylori infection relapse is a major determinant of peptic ulcer recurrence.
- Effective eradication and prevention of H. pylori reinfection are critical for managing peptic ulcer disease and reducing relapse rates.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology